{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T16:00:15Z","timestamp":1778774415635,"version":"3.51.4"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2025,8,23]],"date-time":"2025-08-23T00:00:00Z","timestamp":1755907200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,8,23]],"date-time":"2025-08-23T00:00:00Z","timestamp":1755907200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1007\/s10067-025-07659-7","type":"journal-article","created":{"date-parts":[[2025,8,23]],"date-time":"2025-08-23T09:23:30Z","timestamp":1755941010000},"page":"4187-4191","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Evaluation of Endocan, endothelial nitric oxide synthase, and solubleCD89 in children with IgA vasculitis"],"prefix":"10.1007","volume":"44","author":[{"given":"Fehim","family":"Akg\u00fcng\u00f6r","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fatih","family":"Temiz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8361-5558","authenticated-orcid":false,"given":"Ya\u015far","family":"Kandur","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,8,23]]},"reference":[{"key":"7659_CR1","first-page":"569","volume-title":"Textbook of Pediatric Rheumatology","author":"A Bagga","year":"2001","unstructured":"Bagga A, Dillon MJ (2001) Leukocytoclastic vasculitis. In: Cassidy JT, Petty RE (eds) Textbook of Pediatric Rheumatology, 4th edn. Elsevier Health Sciences, London, pp 569\u2013574","edition":"4"},{"issue":"3","key":"7659_CR2","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1007\/s10067-014-2773-1","volume":"35","author":"X Teng","year":"2016","unstructured":"Teng X, Wang Y, Lin N, Sun M, Wu J (2016) Evaluation of serum procalcitonin and C-reactive protein levels as biomarkers of Henoch-Sch\u00f6nlein purpura in pediatric patients. Clin Rheumatol 35(3):667\u2013671. https:\/\/doi.org\/10.1007\/s10067-014-2773-1","journal-title":"Clin Rheumatol"},{"issue":"34","key":"7659_CR3","doi-asserted-by":"publisher","first-page":"20458","DOI":"10.1074\/jbc.271.34.20458","volume":"271","author":"P Lassalle","year":"1996","unstructured":"Lassalle P, Molet S, Janin A, Heyden JV, Tavernier J, Fiers W et al (1996) ESM-1 is a novel human endothelial cell-specific molecule expressed in lung and regulated by cytokines. J Biol Chem 271(34):20458\u201320464. https:\/\/doi.org\/10.1074\/jbc.271.34.20458","journal-title":"J Biol Chem"},{"key":"7659_CR4","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1146\/annurev.pharmtox.44.101802.121844","volume":"46","author":"DM Dudzinski","year":"2006","unstructured":"Dudzinski DM, Igarashi J, Greif D, Michel T (2006) The regulation and pharmacology of endothelial nitric oxide synthase. Annu Rev Pharmacol Toxicol 46:235\u2013276. https:\/\/doi.org\/10.1146\/annurev.pharmtox.44.101802.121844","journal-title":"Annu Rev Pharmacol Toxicol"},{"issue":"12","key":"7659_CR5","doi-asserted-by":"publisher","first-page":"4114","DOI":"10.1002\/art.37683","volume":"64","author":"TR Schoeb","year":"2012","unstructured":"Schoeb TR, Jarmi T, Hicks MJ, Henke S, Zarjou A, Suzuki H et al (2012) Endothelial nitric oxide synthase inhibits the development of autoimmune-mediated vasculitis in mice. Arthritis Rheum 64(12):4114\u20134124. https:\/\/doi.org\/10.1002\/art.37683","journal-title":"Arthritis Rheum"},{"issue":"6","key":"7659_CR6","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1080\/08860220600767327","volume":"28","author":"V Wiwanitkit","year":"2006","unstructured":"Wiwanitkit V (2006) IgA-CD89 complex in IgA nephropathy: a study on molecular function. Ren Fail 28(6):457\u2013459. https:\/\/doi.org\/10.1080\/08860220600767327","journal-title":"Ren Fail"},{"issue":"4","key":"7659_CR7","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1084\/jem.20112005","volume":"209","author":"L Berthelot","year":"2012","unstructured":"Berthelot L, Papista C, Maciel TT, Biarnes-Pelicot M, Tissandie E, Wang PH et al (2012) Transglutaminase is essential for IgA nephropathy development acting through IgA receptors. J Exp Med 209(4):793\u2013806. https:\/\/doi.org\/10.1084\/jem.20112005","journal-title":"J Exp Med"},{"issue":"11","key":"7659_CR8","doi-asserted-by":"publisher","first-page":"e0188718","DOI":"10.1371\/journal.pone.0188718","volume":"12","author":"E Pillebout","year":"2017","unstructured":"Pillebout E, Jamin A, Ayari H, Housset P, Pierre M, Sauvaget V et al (2017) HSPrognosis group. Biomarkers of IgA vasculitis nephritis in children. PLoS One 12(11):e0188718. https:\/\/doi.org\/10.1371\/journal.pone.0188718","journal-title":"PLoS One"},{"issue":"5","key":"7659_CR9","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1080\/08916930232000114535","volume":"36","author":"J Nov\u00e1k","year":"2003","unstructured":"Nov\u00e1k J, Szekanecz Z, Sebesi J, Tak\u00e1ts A, Demeter P, Bene L et al (2003) Elevated levels of anti-Helicobacter pylori antibodies in Henoch-Sch\u00f6nlein purpura. Autoimmunity 36(5):307\u2013311. https:\/\/doi.org\/10.1080\/08916930232000114535","journal-title":"Autoimmunity"},{"issue":"2","key":"7659_CR10","doi-asserted-by":"publisher","first-page":"73","DOI":"10.4274\/Turkderm.43179","volume":"6","author":"C Akg\u00fcn","year":"2012","unstructured":"Akg\u00fcn C, Akbayram S, Kaya A, Temel H, Bilici S, Aktar F et al (2012) The clinical analysis of childhood Henoch-Sch\u00f6nlein purpura patients. TURKDERM-Turkish Arch Dermatol Venereol 6(2):73\u20137. https:\/\/doi.org\/10.4274\/Turkderm.43179","journal-title":"TURKDERM-Turkish Arch Dermatol Venereol"},{"issue":"3","key":"7659_CR11","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/s0952-3278(98)90060-6","volume":"59","author":"N Buyan","year":"1998","unstructured":"Buyan N, Erba\u015f D, Akk\u00f6k N, Oz E, Bibero\u011flu G, Hasano\u011flu E (1998) Role of free oxygen radicals and prostanoids in the pathogenesis of Henoch-Sch\u00f6nlein Purpura. Prostaglandins Leukot Essent Fatty Acids 59(3):181\u2013184. https:\/\/doi.org\/10.1016\/s0952-3278(98)90060-6","journal-title":"Prostaglandins Leukot Essent Fatty Acids"},{"issue":"11","key":"7659_CR12","doi-asserted-by":"publisher","first-page":"1989","DOI":"10.1007\/s00467-011-1905-y","volume":"26","author":"N Keskin","year":"2011","unstructured":"Keskin N, Civilibal M, Elevli M, Koldas M, Duru NS, Ozturk H (2011) Elevated plasma advanced oxidation protein products in children with Henoch-Schonlein purpura. Pediatric Nephrol (Berlin, Germany) 26(11):1989\u20131993. https:\/\/doi.org\/10.1007\/s00467-011-1905-y","journal-title":"Pediatric Nephrol (Berlin, Germany)"},{"issue":"4","key":"7659_CR13","doi-asserted-by":"publisher","first-page":"2695","DOI":"10.3892\/mmr.2014.3057","volume":"11","author":"KS Kim","year":"2015","unstructured":"Kim KS, Lee YA, Ji HI, Song R, Kim JY, Lee SH et al (2015) Increased expression of endocan in arthritic synovial tissues: effects of adiponectin on the expression of endocan in fibroblast-like synoviocytes. Mol Med Rep 11(4):2695\u20132702. https:\/\/doi.org\/10.3892\/mmr.2014.3057","journal-title":"Mol Med Rep"},{"issue":"2","key":"7659_CR14","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1016\/j.jaad.2013.09.013","volume":"70","author":"I Balta","year":"2014","unstructured":"Balta I, Balta S, Koryurek OM, Demirkol S, Mikhailidis DP, Celik T (2014) Serum endocan levels as a marker of disease activity in patients with Beh\u00e7et disease. J Am Acad Dermatol 70(2):291\u2013296. https:\/\/doi.org\/10.1016\/j.jaad.2013.09.013","journal-title":"J Am Acad Dermatol"},{"issue":"5","key":"7659_CR15","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1002\/jcla.21864","volume":"30","author":"P B\u0103l\u0103nescu","year":"2016","unstructured":"B\u0103l\u0103nescu P, L\u0103daru A, B\u0103l\u0103nescu E, Voiosu T, B\u0103icu\u015f C, Dan GA (2016) Endocan, novel potential biomarker for systemic sclerosis: results of a pilot study. J Clin Lab Anal 30(5):368\u2013373. https:\/\/doi.org\/10.1002\/jcla.21864","journal-title":"J Clin Lab Anal"},{"issue":"5","key":"7659_CR16","doi-asserted-by":"publisher","first-page":"1066","DOI":"10.1111\/bjd.12525","volume":"169","author":"I Balta","year":"2013","unstructured":"Balta I, Balta S, Demirkol S, Mikhailidis DP, Celik T, Akhan M et al (2013) Elevated serum levels of endocan in patients with psoriasis vulgaris: correlations with cardiovascular risk and activity of disease. Br J Dermatol 169(5):1066\u20131070. https:\/\/doi.org\/10.1111\/bjd.12525","journal-title":"Br J Dermatol"},{"issue":"3","key":"7659_CR17","doi-asserted-by":"publisher","first-page":"505","DOI":"10.7754\/clin.lab.2013.130333disease","volume":"60","author":"T Voiosu","year":"2014","unstructured":"Voiosu T, B\u0103l\u0103nescu P, Bengu\u015f A, Voiosu A, Baicu\u015f CR, Barbu M et al (2014) Serum endocan levels are increased in patients with inflammatory bowel disease. Clin Lab 60(3):505\u2013510. https:\/\/doi.org\/10.7754\/clin.lab.2013.130333disease","journal-title":"Clin Lab"},{"issue":"2","key":"7659_CR18","first-page":"179","volume":"31","author":"M Felaco","year":"2001","unstructured":"Felaco M, Grilli A, De Lutiis MA, Patruno A, Libertini N, Taccardi AA et al (2001) Endothelial nitric oxide synthase (eNOS) expression and localization in healthy and diabetic rat hearts. Ann Clin Lab Sci 31(2):179\u2013186","journal-title":"Ann Clin Lab Sci"},{"issue":"1\u20132","key":"7659_CR19","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.ejphar.2007.04.009","volume":"567","author":"C Shinbori","year":"2007","unstructured":"Shinbori C, Saito M, Kinoshita Y, Satoh I, Kono T, Hanada T (2007) Cyclohexenonic long-chain fatty alcohol has therapeutic effects on diabetes-induced angiopathy in the rat aorta. Eur J Pharmacol 567(1\u20132):139\u2013144. https:\/\/doi.org\/10.1016\/j.ejphar.2007.04.009","journal-title":"Eur J Pharmacol"},{"issue":"2","key":"7659_CR20","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1016\/j.kint.2021.09.023","volume":"101","author":"A Cambier","year":"2022","unstructured":"Cambier A, Gleeson PJ, Abbad L, Canesi F, da Silva J, Bex-Coudrat J et al (2022) Soluble CD89 is a critical factor for mesangial proliferation in childhood IgA nephropathy. Kidney Int 101(2):274\u2013287. https:\/\/doi.org\/10.1016\/j.kint.2021.09.023","journal-title":"Kidney Int"},{"issue":"12","key":"7659_CR21","doi-asserted-by":"publisher","first-page":"1281","DOI":"10.1038\/ki.2010.314","volume":"78","author":"MT Vuong","year":"2010","unstructured":"Vuong MT, Hahn-Zoric M, Lundberg S, Gunnarsson I, van Kooten C, Wramner L (2010) Association of soluble CD89 levels with disease progression but not susceptibility in IgA nephropathy. Kidney Int 78(12):1281\u20131287. https:\/\/doi.org\/10.1038\/ki.2010.314","journal-title":"Kidney Int"},{"key":"7659_CR22","doi-asserted-by":"publisher","first-page":"833954","DOI":"10.3389\/fphys.2022.833954","volume":"13","author":"S Xu","year":"2022","unstructured":"Xu S, Han S, Dai Y, Wang L, Zhang X, Ding Y (2022) A review of the mechanism of vascular endothelial \u0131njury in \u0131mmunoglobulin A vasculitis. Front Physiol 13:833954. https:\/\/doi.org\/10.3389\/fphys.2022.833954","journal-title":"Front Physiol"},{"key":"7659_CR23","doi-asserted-by":"publisher","first-page":"771619","DOI":"10.3389\/fimmu.2021.771619","volume":"12","author":"Y Song","year":"2021","unstructured":"Song Y, Huang X, Yu G, Qiao J, Cheng J, Wu J et al (2021) Pathogenesis of IgA vasculitis: an up-to-date review. Front Immunol 12:771619. https:\/\/doi.org\/10.3389\/fimmu.2021.771619","journal-title":"Front Immunol"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-025-07659-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10067-025-07659-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-025-07659-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T14:27:05Z","timestamp":1760365625000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10067-025-07659-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,23]]},"references-count":23,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2025,10]]}},"alternative-id":["7659"],"URL":"https:\/\/doi.org\/10.1007\/s10067-025-07659-7","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"value":"0770-3198","type":"print"},{"value":"1434-9949","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,23]]},"assertion":[{"value":"17 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 August 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 August 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 August 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"Ethical approval for the study was obtained from the Clinical Research Ethics Committee of S\u00fct\u00e7\u00fc \u0130mam University (Date: 25.12.2019 Decision No: 2019\u201324-05) and written informed consent was obtained from all participating patients prior to enrollment. The study adhered to the principles outlined in the Declaration of Helsinki and followed the International Council on Harmonization Guidelines for Good Clinical Practice.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"None.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosures"}}]}}